A prospective, open-label trial to investigate the rapid and sustained response to anakinra in patients suffering from severe cryopyrin-associated periodic syndromes.
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2015
At a glance
- Drugs Anakinra (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Therapeutic Use
- 29 Dec 2015 New trial record